Bank of Montreal
SMMT icon

Bank of Montreal’s Summit Therapeutics SMMT Stock Holding History

Bank of Montreal’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
104,625
-3,334
-3% -$59.1K ﹤0.01% 1871
2026
Q1 		$2.05M Buy
107,959
+12,588
+13% +$204K ﹤0.01% 1660
2025
Q4 		$1.67M Sell
95,371
-2,647
-3% -$49.8K ﹤0.01% 1730
2025
Q3 		$2.03M Sell
98,018
-2,502
-2% -$60.7K ﹤0.01% 1645
2025
Q2 		$2.14M Sell
100,520
-83,505
-45% -$1.9M ﹤0.01% 1560
2025
Q1 		$3.55M Buy
184,025
+99,800
+118% +$2M ﹤0.01% 1298
2024
Q4 		$1.5M Sell
84,225
-13,350
-14% -$259K ﹤0.01% 1672
2024
Q3 		$2.04M Buy
+97,575
New +$1.36M ﹤0.01% 1692
2024
Q2 		– Sell
-589,566
Closed -$2.72M – 4210
2024
Q1 		$2.72M Buy
589,566
+563,266
+2,142% +$2.24M ﹤0.01% 1478
2023
Q4 		$74.7K Buy
+26,300
New +$54.1K ﹤0.01% 3453
2022
Q4 		– Sell
-28,500
Closed -$35K – 4256
2022
Q3 		$35K Buy
+28,500
New +$32.2K ﹤0.01% 3701
2018
Q2 		– Sell
-260
Closed -$3K – 4856
2018
Q1 		$3K Hold
260
– – ﹤0.01% 4004
2017
Q4 		$3K Hold
260
– – ﹤0.01% 4008
2017
Q3 		$3K Buy
+260
New +$3.37K ﹤0.01% 3973

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Bank of Montreal's SMMT Position: Q2 2026 in Review

Bank of Montreal reduced its Summit Therapeutics (SMMT) stake by 3.1% in Q2 2026, selling an estimated $59.1K and leaving 104,625 shares worth $1.52M. The position accounts for ﹤0.01% of the portfolio, ranked #1871.

Bank of Montreal first reported a position in SMMT in Q3 2017 and has held it in 14 quarters since. The position peaked at $3.55M in Q1 2025. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Bank of Montreal held 104,625 shares of Summit Therapeutics worth $1.52M as of Q2 2026.
  • Bank of Montreal sold 3,334 Summit Therapeutics shares in Q2 2026, an estimated $59.1K.
  • Summit Therapeutics made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1871 holding.
  • Bank of Montreal first reported a position in Summit Therapeutics in Q3 2017 and has held it in 14 quarters since.
  • Bank of Montreal's Summit Therapeutics position peaked at $3.55M in Q1 2025.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.